Delivery Order SPE2DB22D1002-SPE2DB24FLFJ4
Award Date
7/24/24
Potential Completion Date
7/25/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $10,804.95 and a completion date of June 21, 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. In addition to this specific...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML. The contract has a ceiling value of $95,105.97 and a completion date of May 30, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $1,143.30. The contract has a firm fixed price pricing type and an ultimate completion date of May 6, 2024. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the...
This is a $1,749.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML medical supplies, with a completion date of January 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML. The contract has a ceiling value of $2,420.70 and runs through March 28, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a total ceiling value of $3,215.14 and is a firm fixed price delivery order with a period of performance through May 9, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, with expertise...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,905.50 contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 22, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is the prime contractor. Amerisourcebergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $29,466.47. The contract is a firm fixed-price, non-set-aside delivery order with a performance period ending on June 26, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,323.40, is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE medication. The contract is a Firm Fixed Price, non-set-aside award with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $3,586.86 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product. The contract has an ultimate completion date of June 13, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop...